Medical information Clinical review pending

Infection Testing

CCHF Crimean Congo Hemorrhagic Fever RNA Detection Qualitative Test

Detects the Crimean Congo Hemorrhagic Fever (CCHF) virus using Real Time PCR technology. Essential for diagnosing CCHF, a viral disease transmitted by ticks, especially in individuals with relevant symptoms or exposure history.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Whole blood, serum, plasma, or cerebrospinal fluid (C.S.F.). Confirm specific requirements with the laboratory before booking.
Results: Results are typically available within 48 hours via email. Confirm exact turnaround time with the laboratory before booking.
Preparation: No specific patient preparation is required. Ensure the patient is informed about the test procedure. A consent document must be signed.

Test priceKSh 11,560

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the CCHF Crimean Congo Hemorrhagic Fever RNA Detection Qualitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Individuals experiencing symptoms suggestive of CCHF (e.g., fever, headache, muscle pain, bleeding).
✓Patients with a history of tick bites in endemic areas.
✓Individuals with known contact with infected animals or humans.
✓Travelers returning from regions where CCHF is prevalent.
✓Public health surveillance during outbreaks.

In plain language

What this test helps you understand

This test is used to confirm or rule out an active CCHF infection by detecting the virus's genetic material (RNA). It aids in the diagnosis of CCHF, guiding appropriate patient management and infection control measures.

The CCHF Crimean Congo Hemorrhagic Fever RNA Detection Qualitative Test is a vital diagnostic tool designed to detect the presence of the Crimean Congo Hemorrhagic Fever (CCHF) virus in patients. CCHF is a viral hemorrhagic fever caused by the Crimean-Congo hemorrhagic fever virus, which is primarily transmitted through tick bites or contact with infected animals or humans. Early diagnosis is crucial for effective management and treatment.

This test utilizes Real Time PCR technology to qualitatively detect the RNA of the CCHF virus in various sample types, including whole blood, serum, plasma, and cerebrospinal fluid (C.S.F.). By identifying the virus's genetic material, healthcare providers can confirm the presence of the infection and initiate appropriate treatment.

Benefits of taking this test include early detection of CCHF, which can significantly improve patient outcomes. Timely diagnosis allows for immediate medical intervention and treatment, and helps in preventing the spread of the virus to others. It also provides peace of mind for patients and their families.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo specific patient preparation is required. Ensure the patient is informed about the test procedure. A consent document must be signed.

SampleWhole blood, serum, plasma, or cerebrospinal fluid (C.S.F.). Confirm specific requirements with the laboratory before booking.

MethodologyReal Time Polymerase Chain Reaction (PCR).

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test detects the presence of viral RNA, indicating an active infection. It does not measure the level of virus (viral load). False negatives may occur if the sample is collected too early or late in the infection, or if the sample quality is poor. False positives are rare but possible due to contamination. Results must be interpreted in the context of clinical presentation and exposure history.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

CCHF stands for Crimean Congo Hemorrhagic Fever. It is a viral disease transmitted primarily by ticks, which can cause severe illness.

CCHF is mainly spread through tick bites or contact with infected animal blood or tissues during and immediately after slaughter. Human-to-human transmission can occur from close contact with the blood, secretions, organs or other bodily fluids of infected persons.

Symptoms can include sudden onset of fever, headache, muscle aches, dizziness, and potentially progressing to bleeding, bruising, and organ failure.

The Real Time PCR test is highly accurate for detecting the CCHF virus RNA when performed correctly on appropriate samples. However, timing of sample collection relative to symptom onset can affect sensitivity.

A positive result indicates the presence of the CCHF virus. Immediate medical attention and appropriate management are necessary. The laboratory will report the result to public health authorities as required.

Yes, a home sample collection service is available for your convenience. Please contact the laboratory to arrange this service.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp